Cabio Biotech (Wuhan) Co (SHSE:688089) Dividend Yield %: 1.89% (As of Jul. 19, 2026) — 83% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688089 Cabio Biotech (Wuhan) Co Ltd SHSE:688089
67 GF Score
Price ¥10.61
GF Value ¥20.66
Valuation Possible Value Trap
! 10 Warning Signs
View Full Analysis

What is Cabio Biotech (Wuhan) Co Dividend Yield %?

Cabio Biotech (Wuhan) Co SHSE:688089 -4.24% 67 Dividend Yield % is 1.89% as of Jul. 19, 2026, which is 83% above its 10-year median of 1.03. GuruFocus rates SHSE:688089 with a GF Score™ of 67/100 and a GF Value™ of ¥20.66 (Possible Value Trap). The stock has 10 warning signs investors should review. Among 153 Biotechnology companies, Cabio Biotech (Wuhan) Co ranks better than 60.13% on this metric.

As of today (2026-07-19), the Trailing Annual Dividend Yield of Cabio Biotech (Wuhan) Co is 1.89%.

Good Sign:

Cabio Biotech (Wuhan) Co Ltd stock Dividend Yield % is close to 1-year high.

The historical rank and industry rank for Cabio Biotech (Wuhan) Co's Dividend Yield % or its related term are showing as below:

SHSE:688089' s Dividend Yield % Range Over the Past 10 Years
Min: 0.49   Med: 1.03   Max: 3.93
Current: 1.89

During the past 13 years, the highest Dividend Yield of Cabio Biotech (Wuhan) Co was 3.93%. The lowest was 0.49%. And the median was 1.03%.

SHSE:688089's Dividend Yield % is ranked better than
60.13% of 153 companies
in the Biotechnology industry
Industry Median: 1.3 vs SHSE:688089: 1.89

Cabio Biotech (Wuhan) Co's Dividend Payout Ratio for the three months ended in Mar. 2026 was 0.00.

During the past 13 years, the highest Dividend Payout Ratio of Cabio Biotech (Wuhan) Co was 1.27. The lowest was 0.26. And the median was 0.60.

As of today (2026-07-19), the Forward Dividend Yield % of Cabio Biotech (Wuhan) Co is 0.00%.

Cabio Biotech (Wuhan) Co's Dividends per Share for the three months ended in Mar. 2026 was ¥0.00.

During the past 12 months, Cabio Biotech (Wuhan) Co's average Dividends Per Share Growth Rate was 0.50% per year. During the past 3 years, the average Dividends Per Share Growth Rate was -5.20% per year. During the past 5 years, the average Dividends Per Share Growth Rate was -8.60% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Cabio Biotech (Wuhan) Co was -5.20% per year. The lowest was -5.60% per year. And the median was -5.40% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Cabio Biotech (Wuhan) Co  (SHSE:688089) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

Cabio Biotech (Wuhan) Co Dividend Yield % Related Terms

Cabio Biotech (Wuhan) Co Dividend Yield % Historical Data

* Premium members only.

The historical data trend for Cabio Biotech (Wuhan) Co's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cabio Biotech (Wuhan) Co Dividend Yield % Chart

Cabio Biotech (Wuhan) Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Dividend Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.54 0.73 1.68 1.05 0.86

Cabio Biotech (Wuhan) Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Dividend Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.81 0.80 0.79 0.86 1.12

SHSE:688089 vs VRTX, REGN, ALNY: Dividend Yield % Comparison

For the Biotechnology subindustry, Cabio Biotech (Wuhan) Co's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cabio Biotech (Wuhan) Co Dividend Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cabio Biotech (Wuhan) Co's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Cabio Biotech (Wuhan) Co's Dividend Yield % falls into.


SHSE:688089
67GF Score
Cabio Biotech (Wuhan) Co Ltd SHSE:688089
Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cabio Biotech (Wuhan) Co Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Frequently Asked Questions Learn more about Dividend Yield % →
What does a Dividend Yield % of 1.89% mean?
Cabio Biotech (Wuhan) Co (SHSE:688089) has a Dividend Yield % of 1.89% as of Jul. 19, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Cabio Biotech (Wuhan) Co and its competitors. This is 83% above median its historical median of 1.03. Over the past decade, Cabio Biotech (Wuhan) Co's Dividend Yield % has ranged from 0.49 to 3.93. According to the industry distribution chart, Cabio Biotech (Wuhan) Co ranks #61 out of 153 companies in the Biotechnology industry, placing it in the top 39.9%.
Is Cabio Biotech (Wuhan) Co's Dividend Yield % too high?
Cabio Biotech (Wuhan) Co's current Dividend Yield % of 1.89% is 83% above median its 10-year median of 1.03. Over the past 10 years, this metric has ranged from a low of 0.49 to a high of 3.93. The Biotechnology industry median Dividend Yield % is 1.30. Cabio Biotech (Wuhan) Co's value of 1.89% is 45.4% above this industry median. Based on the distribution chart, Cabio Biotech (Wuhan) Co ranks #61 out of 153 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Cabio Biotech (Wuhan) Co has a GF Score™ of 67/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Cabio Biotech (Wuhan) Co's Dividend Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Cabio Biotech (Wuhan) Co ranks #61 out of 153 companies for Dividend Yield %. This puts Cabio Biotech (Wuhan) Co in the upper half of its industry. The industry median Dividend Yield % is 1.30. Cabio Biotech (Wuhan) Co's value of 1.89% is 45.4% above this benchmark. Historically, Cabio Biotech (Wuhan) Co's own Dividend Yield % has ranged from 0.49 to 3.93 over the past decade. While the company's 10-year median is 1.03 vs. the industry median of 1.30, Cabio Biotech (Wuhan) Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Biotechnology company?
The median Dividend Yield % among Biotechnology companies is 1.30, based on 153 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cabio Biotech (Wuhan) Co's current Dividend Yield % of 1.89% is 45.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Cabio Biotech (Wuhan) Co and its competitors. For the Biotechnology industry, the median Dividend Yield % is 1.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cabio Biotech (Wuhan) Co's current Dividend Yield % is 1.89%, which is 83% above median its own 10-year median of 1.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cabio Biotech (Wuhan) Co stock overvalued right now?
Based on GuruFocus' analysis, Cabio Biotech (Wuhan) Co (SHSE:688089) is currently considered Possible Value Trap. The stock's GF Value™ is ¥20.66, compared to a current price of ¥10.61 — trading 48.6% below its estimated fair value. The current Dividend Yield % is 1.89%, which is 83% above median its 10-year median of 1.03 and 45.4% above the Biotechnology industry median of 1.30. Cabio Biotech (Wuhan) Co's overall GF Score™ is 67/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Cabio Biotech (Wuhan) Co (SHSE:688089), the current Dividend Yield % is 1.89% as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cabio Biotech (Wuhan) Co (SHSE:688089) Overvalued in 2026?

Based on GuruFocus' analysis, Cabio Biotech (Wuhan) Co stock appears to be undervalued. The current stock price of ¥10.61 is trading 48.6% below its estimated GF Value™ of ¥20.66. GuruFocus considers Cabio Biotech (Wuhan) Co to be Possible Value Trap.

Key valuation signals for SHSE:688089:

  • Dividend Yield %: 1.89% (83% above median its 10-year median of 1.03)
  • GF Value™: ¥20.66 vs. price of ¥10.61 (48.6% below fair value)
  • GF Score™: 67/100 with 10 warning signs
  • Industry Position: 45.4% above the Biotechnology median (#61 of 153)

No single metric tells the full story. See the SHSE:688089 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cabio Biotech (Wuhan) Co Business Description

Address No. 999, Gaoxin Avenue, East Lake New Technology Development Zone, Hubei Province, Wuhan, CHN, 430075
Cabio Biotech (Wuhan) Co Ltd is a biotechnology company, engaged in Research & Development, production and sales of polyunsaturated fatty acids ARA, algae oil DHA and SA, natural B-carotene and other series products. The products are used in infant formula, dietary nutrition supplements and health Food, special medical formula food and other fields. The company's product sales area covers China, the United States, Europe, Australia, New Zealand, South Korea, and Southeast Asia.
67GF Score

Get the complete analysis for SHSE:688089

Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥10.61
Price
¥20.66
GF Value